Trial intelligence / Profile preview

i-PRF in Upper Canine Retraction

NCT03399422Completed

Sponsor
Damascus University
Start
Aug 2017
Primary completion
Aug 2018
Modality
Device-based Delivery
Countries
1
01

Overview

Randomised, single-blind trial of injectable platelet-rich fibrin in malocclusion (2 arms), sponsored by Damascus University. Primary endpoint: Change of the rate of canine retraction. Started Aug 2017; status: completed.

02

Drugs

injectable platelet-rich fibrin
03

Conditions

malocclusion

Beyond the preview

Go deeper on NCT03399422.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03399422.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call